Share chart Mineralys Therapeutics, Inc.
Extended chart
Simple chart
About Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc., биофармацевтическая компания клинической стадии, которая разрабатывает методы лечения гипертонии и связанных с ней сердечно-сосудистых заболеваний. Кандидатом на клиническую стадию является лорундростат, запатентованный пероральный высокоселективный ингибитор альдостеронсинтазы для лечения пациентов с неконтролируемой или резистентной гипертензией. Компания была зарегистрирована в 2019 году и имеет штаб-квартиру в Радноре, штат Пенсильвания.| IPO date | 2023-02-10 |
|---|---|
| ISIN | US6031701013 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://mineralystx.com |
| Цена ао | 13.5 |
| Change price per day: | 0% (13.5) |
|---|---|
| Change price per week: | +28.33% (10.52) |
| Change price per month: | +27% (10.63) |
| Change price per 3 month: | +13.45% (11.9) |
| Change price per half year: | +16.38% (11.6) |
| Change price per year: | +6.38% (12.69) |
| Change price per 3 year: | 0% (13.5) |
| Change price per 5 year: | 0% (13.5) |
| Change price per 10 year: | 0% (13.5) |
| Change price per year to date: | +9.4% (12.34) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Catalys Pacific, LLC | 9194579 | 18.53 |
| Samsara BioCapital, LLC | 4519361 | 9.11 |
| RA Capital Management, L.P. | 3178476 | 6.4 |
| Adams Street Partners, LLC | 2302329 | 4.64 |
| Braidwell LP | 2023900 | 4.08 |
| SR One Capital Management, LP | 1794600 | 3.62 |
| Blackrock Inc. | 1394774 | 2.81 |
| Rock Springs Capital Management, LP | 1167492 | 2.35 |
| Laurion Capital Management, LP | 1156068 | 2.33 |
| Vanguard Group Inc | 977980 | 1.97 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 0.73121 | 63.04 | 0.33 |
| iShares Micro-Cap ETF | 0.08456 | 17.09 | 1.54048 |
| Invesco Nasdaq Biotechnology ETF | 0.05795 | 28.58 | 0.8565 |
| Future Tech ETF | 0.05639 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.05639 | 618.5 | 0.8416 |
| ProShares Ultra Nasdaq Biotechnology | 0.03856 | 51.7 | 0.85651 |
| Avantis U.S Small Cap Equity ETF | 0.02342 | 27.77 | 1.68271 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
ProShares UltraPro Russell2000
|
0.00722 | 89.82 | 1.47873 |
Schwab U.S. Small-Cap ETF
|
0.00693 | 17.47 | 1.51433 |
iShares Russell 2000 Growth ETF
|
0.0045 | 38.04 | 0.6026 |
| Humankind US Stock ETF | 0.00395 | 18.81 | 1.99919 |
| ProShares Hedge Replication ETF | 0.00203 | 5.92 | 1.47892 |
Schwab U.S. Broad Market ETF
|
0.00067 | 24.86 | 1.43354 |
| iShares Russell 3000 ETF | 0.00049 | 24.83 | 1.43482 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| 0.06 | 89.7 | 1.2 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Jon Congleton | CEO & Director | 428.87k | 1963 (62 years) |
| Mr. Adam Scott Levy | CFO & Secretary | 409.17k | 1978 (47 years) |
| Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D. | Founder & Executive Chairman | N/A | 1977 (48 years) |
| Dr. Robert McKean Ph.D. | Senior Vice President of CMC | N/A | |
| Ms. Cindy Berejikian | Executive Vice President of Operations | N/A | |
| Ms. Danielle Bradbury | Senior Vice President of Quality Assurance | N/A | |
| Mr. Jeffrey N. Fellows | Senior Vice President of Regulatory Affairs | N/A | |
| Ms. Jessica Ibbitson | Senior Vice President of Clinical Operations | N/A | |
| Dr. David M. Rodman M.D. | Chief Medical Officer | 423.66k | 1955 (70 years) |
| Ms. Sarah Foster | Vice President of Human Resources | N/A |
Address: United States, Radnor. PA, 150 N. Radnor Chester Rd. - open in Google maps, open in Yandex maps
Website: https://mineralystx.com
Website: https://mineralystx.com
